“Role of Intranasal Midazolam As a Procedural Sedative in Children Aged 6 Months to 12 Years: An Open-Label Randomized Controlled Study”. 2018. Indian Journal of Child Health 5 (1): 1-5. https://doi.org/10.32677/IJCH.2018.v05.i01.001.